Analyst (m/f/d) Market Access at IGES Gruppe | GB | Rezi

Analyst (m/f/d) Market Access at IGES Gruppe

Analyst (m/f/d) Market Access

IGES Gruppe · GB

5 days ago

Analyst (m/f/d) Market Access

IGES Gruppe · GB

5 days ago
Resume preview

Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now
Resume preview

Tailor your resume to this Analyst (m/f/d) Market Access role.

Rezi rewrites your resume against IGES Gruppe's job description. Free.

Resume score gauge reading 58 out of 100

Don't guess if your resume is good enough.

See how it scores against the Analyst (m/f/d) Market Access posting at IGES Gruppe — free, in seconds.

About the Role

This entry-level Analyst position is an ideal first step into consulting, supporting Consultants and the Director in delivering high-quality market access work for pharmaceutical and biotech clients. You will develop consulting-grade skills in a fast-paced, research-driven environment with structured guidance and clear development opportunities.

Responsibilities

  • Support the delivery of diverse market access projects for UK-local or EU accounts, for pharmaceutical and biotech companies.
  • Conduct rigorous secondary research and support primary research, including preparing for and following up on stakeholder interviews.
  • Gather, structure, and analyze data to support client recommendations.
  • Prepare high-quality, client-ready deliverables such as presentations, reports, and analyses.
  • Participate in internal meetings and present individual portions of project deliverables.
  • Support colleagues across other IGES functions in multi-country projects with UK components and UK-specific projects.
  • Continuously develop as a market access professional, demonstrating curiosity, willingness to learn, and taking on responsibility.
  • Support the profile-raising of IGES UK Pharma in the Market Access space and stay updated on NHS policy changes.

Requirements

  • Minimum 2:1 honours degree; a Master's with a health economics background is an advantage.
  • Initial understanding of, or strong interest in, UK market access, pricing, reimbursement, and the NHS system.
  • Relevant exposure to market access, such as internships, study jobs, or early experience in the pharmaceutical or consultancy space.
  • Strong quantitative and analytical skills, structured thinking, and excellent attention to detail.
  • Strong written and verbal communication skills.
  • Proficiency in Microsoft PowerPoint, Word, and Excel.
  • Ability to manage individual tasks and deliver high-quality work to deadlines with appropriate guidance.
  • Eligibility to work in the UK without sponsorship.

Skills

  • Market access
  • Pricing
  • Reimbursement
  • NHS system
  • Secondary research
  • Primary research
  • Data analysis
  • Microsoft PowerPoint
  • Microsoft Word
  • Microsoft Excel
  • Communication skills
  • Analytical skills

Location

  • London

Work Type

  • Hybrid working model

Experience Level

  • Entry-level

Education Level

  • 2:1 honours degree
  • Master's degree

Salary/Compensations

  • Competitive salary

Benefits

  • Opportunity to grow and shape the company
  • Structured development and mentoring
  • Life insurance
  • Pension scheme
  • Private healthcare insurance
  • 25 days holiday
  • Multinational collaboration
  • Hybrid working model

About the Company

  • IGES GmbH specialises in health economic and strategic research and consulting services for international pharmaceutical and medical device manufacturers.
  • Offers biotech, pharmaceutical, and medical device companies solutions for market access, pricing, and reimbursement.
  • Has offices in France, Germany, Italy, Spain, Sweden, Switzerland, and the United Kingdom.
  • Provides support for multinational product launches.
  • IGES is part of the Athagoras Group, which brings together various consulting firms for the life sciences industry.
  • IGES UK Pharma Ltd. is an entity in the UK set up to offer strategic advice for early trial planning and launch of new innovative medicines within the NHS system to secure reimbursement.